(R)-lipoic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 1,4-naphthoquinone increases abundance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased abundance of 1 and 4-naphthoquinone CTD PMID:16243959 1-naphthol increases abundance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased abundance of 1-naphthol CTD PMID:16243959 14,15-EET increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 14 more ... CTD PMID:12675279 17alpha-ethynylestradiol decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Ethinyl Estradiol results in decreased activity of CYP2C8 protein CTD PMID:15601807 17beta-estradiol decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Estradiol results in decreased expression of CYP2C8 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP2C8 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CYP2C79 mRNA CTD PMID:22298810 2,8-bis-Trifluoromethyl-4-quinoline carboxylic acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 Ro 21-5104 results in increased expression of CYP2C8 mRNA CTD PMID:25313206 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Verapamil results in decreased activity of CYP2C8 protein CTD PMID:15304522 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Verapamil results in decreased activity of CYP2C8 protein] CTD PMID:15304522 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 and 2-diphenyl-1-butene CTD PMID:29285606 4-[(1E)-1,2-diphenylbut-1-en-1-yl]phenol multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of 1-(4-hydroxyphenyl)-1 more ... CTD PMID:29285606 4-Hydroxy-N-desmethyltamoxifen decreases activity ISO CYP2C8 (Homo sapiens) 6480464 4-hydroxy-N-desmethyltamoxifen results in decreased activity of CYP2C8 protein CTD PMID:29285606 4-isopropylphenol increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of 4-isopropylphenol CTD PMID:23470418 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime affects binding ISO CYP2C8 (Homo sapiens) 6480464 [6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:15933212 6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime increases expression ISO CYP2C8 (Homo sapiens) 6480464 6-(4-chlorophenyl)imidazo(2 more ... CTD PMID:15933212 6-hydroxypaclitaxel increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 6-hydroxytaxol CTD PMID:12401345 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP2C79 mRNA CTD PMID:24780913 aconitine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Aconitine CTD PMID:21277363 aconitine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Gemfibrozil results in decreased activity of CYP2C8 protein] which affects the chemical synthesis of Aconitine metabolite CTD PMID:21277363 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of CYP2C79 mRNA CTD PMID:28959563 afimoxifene increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of afimoxifene CTD PMID:29285606 afimoxifene decreases activity ISO CYP2C8 (Homo sapiens) 6480464 afimoxifene results in decreased activity of CYP2C8 protein CTD PMID:29285606 aflatoxin B1 affects expression ISO CYP2C8 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of CYP2C8 protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased methylation of CYP2C8 gene CTD PMID:27153756 aflatoxin B1 decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CYP2C8 mRNA CTD PMID:22100608 and PMID:27153756 all-trans-4-hydroxyretinoic acid increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 4-hydroxyretinoic acid CTD PMID:10874126 all-trans-4-oxoretinoic acid increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of 4-oxoretinoic acid CTD PMID:10874126 all-trans-retinoic acid affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Tretinoin CTD PMID:15933212 all-trans-retinoic acid increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Tretinoin CTD PMID:10874126 all-trans-retinoic acid increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Tretinoin CTD PMID:12464242 almotriptan decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased methylation of almotriptan CTD PMID:12642466 aminophenazone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Amoxicillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] and Piperacillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] CTD PMID:26763401 aminophenazone decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased methylation of Aminopyrine CTD PMID:26763401 amiodarone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Amiodarone results in decreased activity of CYP2C8 protein CTD PMID:15304522 amiodarone decreases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased susceptibility to Amiodarone CTD PMID:26477383 amiodarone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Amiodarone results in decreased activity of CYP2C8 protein] CTD PMID:15304522 amiodarone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Amiodarone CTD PMID:15716363 amodiaquine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [5-bromotryptamine analog results in decreased activity of CYP2C8 protein] which results in decreased metabolism of Amodiaquine more ... CTD PMID:15771232 more ... amodiaquine increases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased susceptibility to Amodiaquine CTD PMID:31629065 amodiaquine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Amodiaquine CTD PMID:15155557 more ... amodiaquine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Amodiaquine CTD PMID:12920490 and PMID:15626586 amoxicillin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Amoxicillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] CTD PMID:26763401 amoxicillin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Amoxicillin results in decreased activity of CYP2C8 protein CTD PMID:26763401 arachidonic acid increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Arachidonic Acid CTD PMID:12675279 Aroclor 1254 increases expression ISO CYP2C8 (Homo sapiens) 6480464 Chlorodiphenyl (54% Chlorine) results in increased expression of CYP2C8 mRNA CTD PMID:17851650 Auriculasin increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of auriculasin CTD PMID:31515991 Auriculasin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Quercetin inhibits the reaction [CYP2C8 protein results in increased metabolism of auriculasin] CTD PMID:31515991 benzo[a]pyrene decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CYP2C8 mRNA CTD PMID:32234424 bezafibrate decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Bezafibrate results in decreased expression of CYP2C8 protein CTD PMID:29960002 bis(2-ethylhexyl) phthalate multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Diethylhexyl Phthalate results in increased expression of CYP2C8] which results in increased metabolism of and results in decreased activity of Doxorubicin and Diethylhexyl Phthalate promotes the reaction [AHR protein binds to CYP2C8 promoter] CTD PMID:34801851 bis(2-ethylhexyl) phthalate increases expression ISO CYP2C8 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of CYP2C8 mRNA CTD PMID:34801851 bisphenol A increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of bisphenol A and CYP2C8 protein results in increased hydroxylation of bisphenol A metabolite CTD PMID:23470418 bisphenol A decreases activity ISO CYP2C8 (Homo sapiens) 6480464 bisphenol A results in decreased activity of CYP2C8 protein CTD PMID:10784435 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP2C8 mRNA CTD PMID:25181051 bisphenol A increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of bisphenol A and CYP2C8 protein results in increased glutathionylation of bisphenol A metabolite CTD PMID:23470418 bisphenol F increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of 4 and 4'-bisphenol F CTD PMID:23470418 bisphenol F increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of 4 and 4'-bisphenol F CTD PMID:23470418 bromfenac increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of bromfenac CTD PMID:31815452 Bufuralol increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of bufuralol CTD PMID:9429232 buprenorphine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Buprenorphine CTD PMID:16010532 butyric acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 Butyric Acid results in increased expression of CYP2C8 mRNA CTD PMID:30439556 camptothecin decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Camptothecin results in decreased expression of CYP2C8 mRNA CTD PMID:29356861 camptothecin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Camptothecin inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA] CTD PMID:29356861 Candesartan cilexetil decreases activity ISO CYP2C8 (Homo sapiens) 6480464 candesartan cilexetil results in decreased activity of CYP2C8 protein CTD PMID:15601807 carbamazepine increases expression ISO CYP2C8 (Homo sapiens) 6480464 Carbamazepine results in increased expression of CYP2C8 mRNA CTD PMID:17112801 carbamazepine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Carbamazepine CTD PMID:15286053 and PMID:15915352 carbamazepine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Carbamazepine CTD PMID:12464242 carbamazepine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Probenecid promotes the reaction [CYP2C8 protein affects the metabolism of Carbamazepine] CTD PMID:15915352 carbamazepine-10,11-epoxide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Probenecid promotes the reaction [CYP2C8 protein affects the chemical synthesis of carbamazepine epoxide] CTD PMID:15915352 carbamazepine-10,11-epoxide affects chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the chemical synthesis of carbamazepine epoxide CTD PMID:15915352 carfentanil increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of carfentanil CTD PMID:33652071 cerivastatin affects response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene mutant form affects the susceptibility to cerivastatin CTD PMID:15365880 cerivastatin increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of cerivastatin CTD PMID:12464242 more ... chenodeoxycholic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Chenodeoxycholic Acid results in decreased expression of CYP2C8 mRNA CTD PMID:27174168 chenodeoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 chloroquine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 polymorphism affects the metabolism of Chloroquine and CYP2C8 protein affects the metabolism of Chloroquine CTD PMID:12920490 and PMID:19560616 chloroquine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine and Quercetin inhibits the reaction [[CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine] CTD PMID:12756207 and PMID:12967198 chloroquine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Chloroquine CTD PMID:17286541 chlorpromazine decreases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased susceptibility to Chlorpromazine CTD PMID:26477383 cinitapride increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of cinitapride CTD PMID:17437965 clofibric acid increases activity ISO CYP2C8 (Homo sapiens) 6480464 Clofibric Acid results in increased activity of CYP2C8 protein CTD PMID:15771232 clofibric acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 Clofibric Acid results in increased expression of CYP2C8 mRNA and Clofibric Acid results in increased expression of CYP2C8 protein CTD PMID:15771232 Clofop increases activity ISO CYP2C8 (Homo sapiens) 6480464 fenofibric acid results in increased activity of CYP2C8 protein CTD PMID:15771232 Clofop increases expression ISO CYP2C8 (Homo sapiens) 6480464 fenofibric acid results in increased expression of CYP2C8 mRNA and fenofibric acid results in increased expression of CYP2C8 protein CTD PMID:15771232 clopidogrel multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of and results in increased cleavage of clopidogrel metabolite CTD PMID:19170597 clotrimazole decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Clotrimazole results in decreased activity of CYP2C8 protein CTD PMID:15601807 and PMID:33775687 clozapine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Clozapine CTD PMID:18809730 and PMID:27320963 Clozapine N-oxide increases abundance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased abundance of clozapine N-oxide CTD PMID:27320963 cocaine decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Cocaine results in decreased expression of CYP2C8 mRNA and Cocaine results in decreased expression of CYP2C8 protein CTD PMID:16188404 cumene hydroperoxide affects oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the oxidation of cumene hydroperoxide CTD PMID:17478480 cyclophosphamide increases activity ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 results in increased activity of Cyclophosphamide CTD PMID:9241661 cyclosporin A decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CYP2C8 mRNA CTD PMID:20106945 cyclosporin A affects oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the oxidation of Cyclosporine CTD PMID:7870052 cylindrospermopsin decreases expression ISO CYP2C8 (Homo sapiens) 6480464 cylindrospermopsin results in decreased expression of CYP2C8 mRNA CTD PMID:30905859 cypermethrin increases expression ISO CYP2C8 (Homo sapiens) 6480464 cypermethrin results in increased expression of CYP2C8 mRNA CTD PMID:22310298 dabrafenib decreases activity ISO CYP2C8 (Homo sapiens) 6480464 dabrafenib results in decreased activity of CYP2C8 protein CTD PMID:34780725 dapsone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Dapsone CTD PMID:17286541 deoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 Desethylchloroquine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine and Quercetin inhibits the reaction [[CYP2C8 protein results in increased metabolism of Chloroquine] which results in increased abundance of desethylchloroquine] CTD PMID:12756207 and PMID:12967198 dexamethasone affects binding ISO CYP2C8 (Homo sapiens) 6480464 [Dexamethasone binds to NR3C1 protein] which binds to CYP2C8 promoter CTD PMID:15933212 dexamethasone increases expression ISO CYP2C8 (Homo sapiens) 6480464 Dexamethasone results in increased expression of CYP2C8 mRNA CTD PMID:15933212 and PMID:19118567 Dihydrotanshinone I decreases activity ISO CYP2C8 (Homo sapiens) 6480464 dihydrotanshinone I results in decreased activity of CYP2C8 protein CTD PMID:29689254 diosmetin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 diosmetin results in decreased activity of CYP2C8 protein CTD PMID:28867436 domperidone increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Domperidone CTD PMID:15327587 doxorubicin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Diethylhexyl Phthalate results in increased expression of CYP2C8] which results in increased metabolism of and results in decreased activity of Doxorubicin CTD PMID:34801851 felbamate increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Felbamate CTD PMID:35786679 felodipine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Felodipine results in decreased activity of CYP2C8 protein CTD PMID:15601807 and PMID:28119166 felodipine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Felodipine inhibits the reaction [CYP2C8 protein results in increased metabolism of Amodiaquine] CTD PMID:28119166 fenitrothion decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Fenitrothion results in decreased activity of CYP2C8 protein CTD PMID:20183062 fenofibrate decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Fenofibrate results in decreased activity of CYP2C8 protein CTD PMID:15601807 fenofibrate affects expression ISO CYP2C8 (Homo sapiens) 6480464 Fenofibrate affects the expression of CYP2C8 protein CTD PMID:29960002 fenofibrate increases expression ISO CYP2C8 (Homo sapiens) 6480464 Fenofibrate results in increased expression of CYP2C8 mRNA CTD PMID:25572481 fenvalerate increases expression ISO CYP2C8 (Homo sapiens) 6480464 fenvalerate results in increased expression of CYP2C8 mRNA CTD PMID:22310298 fipronil increases expression ISO CYP2C8 (Homo sapiens) 6480464 fipronil results in increased expression of CYP2C8 mRNA CTD PMID:27091632 fipronil multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2C8 mRNA CTD PMID:27091632 fluoxetine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Fluoxetine results in decreased activity of CYP2C8 protein CTD PMID:15304522 fluoxetine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Fluoxetine results in decreased activity of CYP2C8 protein] CTD PMID:15304522 furan decreases expression EXP 6480464 furan results in decreased expression of CYP2C79 mRNA CTD PMID:26194646 gemfibrozil multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Gemfibrozil co-treated with Amodiaquine] results in decreased activity of CYP2C8 protein more ... CTD PMID:15771232 more ... gemfibrozil increases expression ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil results in increased expression of CYP2C8 mRNA CTD PMID:15771232 gemfibrozil decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil results in decreased expression of CYP2C8 protein CTD PMID:15771232 and PMID:29960002 gemfibrozil decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil metabolite results in decreased activity of CYP2C8 protein and Gemfibrozil results in decreased activity of CYP2C8 protein CTD PMID:15771232 and PMID:16042675 glutathione multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein co-treated with GSTP1 protein co-treated with Glutathione] results in increased abundance of 2'-(glutathion-S-yl)-deschlorodiclofenac CTD PMID:24246759 glycochenodeoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 glycocholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 glycodeoxycholic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA and [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 glyoxal multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [CYP2C8 protein results in increased metabolism of and results in increased susceptibility to sudoxicam] which results in increased chemical synthesis of Glyoxal CTD PMID:33253783 Hypaconitine increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of hypaconitine CTD PMID:21550385 ibuprofen affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene polymorphism affects the metabolism of Ibuprofen CTD PMID:15606441 ibuprofen increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene polymorphism results in increased metabolism of Ibuprofen CTD PMID:18694831 ibuprofen decreases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene polymorphism results in decreased metabolism of Ibuprofen CTD PMID:15289789 ifosfamide increases activity ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 results in increased activity of Ifosfamide CTD PMID:9241661 irbesartan decreases activity ISO CYP2C8 (Homo sapiens) 6480464 irbesartan results in decreased activity of CYP2C8 protein CTD PMID:15601807 isoniazide decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Isoniazid results in decreased activity of CYP2C8 protein CTD PMID:15304522 isoniazide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Isoniazid results in decreased activity of CYP2C8 protein] CTD PMID:15304522 ketoconazole decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP2C8 protein CTD PMID:14709627 and PMID:15601807 ketoconazole multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Ketoconazole affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 lansoprazole affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Lansoprazole CTD PMID:7870052 lansoprazole increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Lansoprazole CTD PMID:8627562 Licochalcone A decreases activity ISO CYP2C8 (Homo sapiens) 6480464 licochalcone A results in decreased activity of CYP2C8 protein CTD PMID:26100226 lipoic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Thioctic Acid inhibits the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 loratadine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Loratadine results in decreased activity of CYP2C8 protein CTD PMID:15601807 lovastatin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Lovastatin results in decreased activity of CYP2C8 protein CTD PMID:15601807 masitinib increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of masitinib CTD PMID:36048877 medroxyprogesterone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Medroxyprogesterone results in decreased activity of CYP2C8 protein CTD PMID:15601807 MeIQx decreases expression ISO CYP2C8 (Homo sapiens) 6480464 2-amino-3 more ... CTD PMID:20816883 methoxychlor decreases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased methylation of Methoxychlor CTD PMID:12167570 and PMID:12433799 methyltestosterone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Methyltestosterone co-treated with Cholic Acids] affects the expression of CYP2C8 mRNA CTD PMID:27344345 mometasone furoate decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Mometasone Furoate results in decreased activity of CYP2C8 protein CTD PMID:15601807 montelukast decreases activity ISO CYP2C8 (Homo sapiens) 6480464 montelukast results in decreased activity of CYP2C8 protein CTD PMID:15601807 more ... montelukast increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of montelukast CTD PMID:19309152 mycophenolic acid increases methylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased methylation of Mycophenolic Acid CTD PMID:15570183 N,N-diethyl-m-toluamide increases expression ISO CYP2C8 (Homo sapiens) 6480464 DEET results in increased expression of CYP2C8 mRNA CTD PMID:27091632 N,N-diethyl-m-toluamide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP2C8 mRNA CTD PMID:27091632 N-desmethylclozapine increases chemical synthesis ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased chemical synthesis of norclozapine CTD PMID:18809730 NADP zwitterion multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid more ... CTD PMID:24120545 NADP(+) multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid more ... CTD PMID:24120545 naphthalene increases expression ISO CYP2C8 (Homo sapiens) 6480464 naphthalene results in increased expression of CYP2C8 mRNA CTD PMID:20500019 Neferine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of and results in decreased methylation of neferine CTD PMID:25451576 Neferine increases glutathionylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased glutathionylation of neferine metabolite CTD PMID:25451576 nicardipine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Nicardipine CTD PMID:15863898 nicardipine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Nicardipine results in decreased activity of CYP2C8 protein CTD PMID:15863898 nifedipine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Nifedipine results in decreased activity of CYP2C8 protein CTD PMID:15601807 nortriptyline decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Nortriptyline results in decreased activity of CYP2C8 protein CTD PMID:15304522 nortriptyline multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Nortriptyline results in decreased activity of CYP2C8 protein] CTD PMID:15304522 O-methyleugenol decreases expression ISO CYP2C8 (Homo sapiens) 6480464 methyleugenol results in decreased expression of CYP2C8 mRNA CTD PMID:32234424 obeticholic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 obeticholic acid results in decreased expression of CYP2C8 mRNA CTD PMID:27939613 oxybutynin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 oxybutynin results in decreased activity of CYP2C8 protein CTD PMID:15601807 paclitaxel increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Paclitaxel CTD PMID:12401345 more ... paclitaxel increases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 mRNA results in increased susceptibility to Paclitaxel CTD PMID:15239142 paclitaxel increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Paclitaxel CTD PMID:21964418 paclitaxel affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Paclitaxel CTD PMID:15901749 and PMID:15933212 paclitaxel affects response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene SNP affects the susceptibility to Paclitaxel CTD PMID:27736846 paclitaxel increases oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of Paclitaxel CTD PMID:17478480 paclitaxel multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Cyclohexenes analog inhibits the reaction [CYP2C8 protein results in increased metabolism of Paclitaxel] more ... CTD PMID:20452209 more ... paracetamol decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP2C8 mRNA CTD PMID:29067470 paracetamol multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with Acetaminophen] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 parathion affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Parathion CTD PMID:12669189 pazopanib increases expression ISO CYP2C8 (Homo sapiens) 6480464 pazopanib results in increased expression of CYP2C8 mRNA CTD PMID:29356861 perfluorooctane-1-sulfonic acid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 perfluorooctane sulfonic acid inhibits the reaction [CYP2C8 protein results in increased hydroxylation of Paclitaxel] CTD PMID:21964418 perfluorooctane-1-sulfonic acid increases expression ISO CYP2C8 (Homo sapiens) 6480464 perfluorooctane sulfonic acid results in increased expression of CYP2C8 mRNA CTD PMID:27153767 and PMID:32588087 phencyclidine affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of Phencyclidine CTD PMID:16782764 Phenelzine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Phenelzine results in decreased activity of CYP2C8 protein] CTD PMID:15304522 Phenelzine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Phenelzine results in decreased activity of CYP2C8 protein CTD PMID:15304522 phenobarbital increases expression ISO CYP2C8 (Homo sapiens) 6480464 Phenobarbital results in increased expression of CYP2C29 protein more ... CTD PMID:19118567 more ... pimecrolimus multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 pimecrolimus inhibits the reaction [Rifampin results in increased expression of CYP2C8 mRNA] CTD PMID:29356861 pioglitazone multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Gemfibrozil inhibits the reaction [CYP2C8 protein affects the metabolism of pioglitazone] CTD PMID:15900286 pioglitazone increases expression ISO CYP2C8 (Homo sapiens) 6480464 Pioglitazone results in increased expression of CYP2C8 mRNA CTD PMID:31233785 pioglitazone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 pioglitazone results in decreased activity of CYP2C8 protein CTD PMID:12642470 pioglitazone affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of pioglitazone CTD PMID:15900286 piperacillin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Piperacillin results in decreased activity of CYP2C8 protein CTD PMID:26763401 piperacillin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Piperacillin inhibits the reaction [CYP2C8 protein results in decreased methylation of Aminopyrine] CTD PMID:26763401 pirinixic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 pirinixic acid results in decreased expression of CYP2C8 protein CTD PMID:29960002 probenecid multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Probenecid promotes the reaction [CYP2C8 protein affects the chemical synthesis of carbamazepine epoxide] and Probenecid promotes the reaction [CYP2C8 protein affects the metabolism of Carbamazepine] CTD PMID:15915352 progesterone increases expression ISO CYP2C8 (Homo sapiens) 6480464 Progesterone results in increased expression of CYP2C8 mRNA CTD PMID:22837389 quercetin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Quercetin results in decreased activity of CYP2C8 protein CTD PMID:15155557 more ... quercetin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Quercetin results in decreased activity of CYP2C8 protein] which results in decreased degradation of vanoxerine more ... CTD PMID:11502731 more ... raloxifene decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Raloxifene Hydrochloride results in decreased activity of CYP2C8 protein CTD PMID:15601807 resveratrol decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Resveratrol results in decreased activity of CYP2C8 protein CTD PMID:30394306 rifampicin increases expression ISO CYP2C8 (Homo sapiens) 6480464 Rifampin results in increased expression of CYP2C8 mRNA and Rifampin results in increased expression of CYP2C8 protein CTD PMID:12040753 more ... rifampicin multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Rifampin inhibits the reaction [CYP2C8 protein results in increased susceptibility to Amodiaquine]] which results in decreased expression of BCL2 protein more ... CTD PMID:29356861 and PMID:31629065 rifampicin increases activity ISO CYP2C8 (Homo sapiens) 6480464 Rifampin results in increased activity of CYP2C8 protein CTD PMID:15771232 and PMID:22126990 rifampicin affects binding ISO CYP2C8 (Homo sapiens) 6480464 [Rifampin binds to NR1I2 protein] which binds to CYP2C8 promoter CTD PMID:15933212 ritonavir decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Ritonavir results in decreased activity of CYP2C8 protein CTD PMID:15601807 Salmeterol xinafoate decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Salmeterol Xinafoate results in decreased activity of CYP2C8 protein CTD PMID:15601807 Salvianolic acid A decreases activity ISO CYP2C8 (Homo sapiens) 6480464 salvianolic acid A results in decreased activity of CYP2C8 protein CTD PMID:29689254 Salvianolic acid C decreases activity ISO CYP2C8 (Homo sapiens) 6480464 salvianolic acid C results in decreased activity of CYP2C8 protein CTD PMID:29689254 satraplatin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 satraplatin results in decreased activity of CYP2C8 protein CTD PMID:24882083 Senkirkine decreases expression ISO CYP2C8 (Homo sapiens) 6480464 senkirkine results in decreased expression of CYP2C8 mRNA CTD PMID:26100227 silibinin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Silybin results in decreased activity of CYP2C8 protein CTD PMID:28457856 silicon dioxide decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of CYP2C8 mRNA CTD PMID:25895662 simvastatin decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Simvastatin results in decreased activity of CYP2C8 protein CTD PMID:15601807 sodium arsenite decreases expression ISO CYP2C8 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CYP2C8 mRNA CTD PMID:29301061 and PMID:34032870 sorafenib decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Sorafenib metabolite results in decreased activity of CYP2C8 protein and Sorafenib results in decreased activity of CYP2C8 protein CTD PMID:33556367 spironolactone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Spironolactone results in decreased activity of CYP2C8 protein CTD PMID:15601807 sporidesmin A affects expression ISO CYP2C8 (Homo sapiens) 6480464 sporidesmin affects the expression of CYP2C8 mRNA CTD PMID:28193462 sporidesmin A multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 MIR21 mRNA affects the reaction [sporidesmin affects the expression of CYP2C8 mRNA] CTD PMID:28193462 Sudan I increases oxidation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of 1-phenylazo-2-naphthol CTD PMID:17159775 sulfadiazine increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Sulfadiazine CTD PMID:15843491 sulfinpyrazone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Sulfinpyrazone results in decreased activity of CYP2C8 protein CTD PMID:12464242 Sunset Yellow FCF multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Glycochenodeoxycholic Acid co-treated with Deoxycholic Acid co-treated with Chenodeoxycholic Acid co-treated with Glycodeoxycholic Acid co-treated with Glycocholic Acid co-treated with 6-hydroxy-5-((p- sulfophenyl)azo)-2-naphthalenesulfonic acid disodium salt] results in decreased expression of CYP2C8 mRNA CTD PMID:33819548 tamoxifen decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Tamoxifen results in decreased activity of CYP2C8 protein CTD PMID:15601807 and PMID:29285606 tamoxifen increases activity ISO CYP2C8 (Homo sapiens) 6480464 Tamoxifen metabolite results in increased activity of CYP2C8 protein CTD PMID:29285606 Tanshinone I decreases activity ISO CYP2C8 (Homo sapiens) 6480464 tanshinone results in decreased activity of CYP2C8 protein CTD PMID:29689254 tetrachloroethene increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Tetrachloroethylene CTD PMID:11684365 Thiocoraline affects metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein affects the metabolism of thiocoraline CTD PMID:15122071 thyroxine decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Thyroxine results in decreased activity of CYP2C8 protein CTD PMID:15601807 ticlopidine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased oxidation of and results in increased cleavage of Ticlopidine metabolite CTD PMID:19170597 tolbutamide increases hydroxylation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased hydroxylation of Tolbutamide CTD PMID:15843491 torasemide multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Torsemide inhibits the reaction [Amiodarone results in decreased activity of CYP2C8 protein] more ... CTD PMID:15304522 torasemide increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Torsemide CTD PMID:15304522 trans-cinnamic acid decreases activity ISO CYP2C8 (Homo sapiens) 6480464 cinnamic acid analog results in decreased activity of CYP2C8 protein CTD PMID:15072549 tranylcypromine multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 Tranylcypromine affects the reaction [[NADP co-treated with CYP1A2 protein co-treated with CYP2C8 protein co-treated with CYP2C9 protein co-treated with CYP2C19 protein co-treated with CYP2D6 protein co-treated with CYP3A4 protein co-treated with POR protein] results in increased metabolism of 1-(3-(4-phenoxyphenoxy)-2-oxopropyl)indole-5-carboxylic acid] CTD PMID:24120545 triflumuron increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of triflumuron CTD PMID:31082524 trimethoprim increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of Trimethoprim CTD PMID:12464242 trimethoprim decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Trimethoprim results in decreased activity of CYP2C8 protein CTD PMID:15570183 Triptolide decreases expression EXP 6480464 triptolide results in decreased expression of CYP2C8 protein CTD PMID:33600922 troglitazone decreases activity ISO CYP2C8 (Homo sapiens) 6480464 troglitazone results in decreased activity of CYP2C8 protein CTD PMID:12642470 troglitazone increases expression ISO CYP2C8 (Homo sapiens) 6480464 troglitazone results in increased expression of CYP2C8 mRNA CTD PMID:25572481 troglitazone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of troglitazone CTD PMID:19356091 tryptamines multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Tryptamines analog results in decreased activity of CYP2C8 protein] which results in decreased metabolism of Amodiaquine CTD PMID:26599973 tryptamines decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Tryptamines analog results in decreased activity of CYP2C8 protein CTD PMID:26599973 valproic acid decreases expression ISO CYP2C8 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP2C8 mRNA CTD PMID:29501571 vanoxerine dihydrochloride decreases degradation ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in decreased degradation of vanoxerine CTD PMID:11502731 vanoxerine dihydrochloride multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 [Quercetin results in decreased activity of CYP2C8 protein] which results in decreased degradation of vanoxerine CTD PMID:11502731 verapamil multiple interactions ISO CYP2C8 (Homo sapiens) 6480464 torsemide inhibits the reaction [Verapamil results in decreased activity of CYP2C8 protein] CTD PMID:15304522 verapamil decreases activity ISO CYP2C8 (Homo sapiens) 6480464 Verapamil results in decreased activity of CYP2C8 protein CTD PMID:15304522 vincristine increases response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 gene SNP results in increased susceptibility to Vincristine CTD PMID:21245421 warfarin affects response to substance ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 polymorphism affects the susceptibility to Warfarin CTD PMID:34382722 zafirlukast decreases activity ISO CYP2C8 (Homo sapiens) 6480464 zafirlukast results in decreased activity of CYP2C8 protein CTD PMID:15601807 zopiclone increases metabolic processing ISO CYP2C8 (Homo sapiens) 6480464 CYP2C8 protein results in increased metabolism of zopiclone CTD PMID:12464242